The USP Pharmaceutical Product Quality Testing program is a voluntary testing option for generic drug manufacturers to showcase their commitment to and investment in the quality of their medicines.
The program will test products from the commercial supply chain using only scientifically validated quality testing methods – either found in USP’s public quality standards published in the United States Pharmacopeia – National Formulary (USP-NF) or those accepted by the U.S. Food and Drug Administration (FDA).
USP will share passing testing results with organizations that purchase generic medicines to inform purchasing and procurement decisions.